Literature DB >> 14691730

The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval.

Alexander Zimprich1, Bertram Müller-Myhsok, Matthew Farrer, Petra Leitner, Manu Sharma, Mary Hulihan, Paul Lockhart, Audrey Strongosky, Jennifer Kachergus, Donald B Calne, Jon Stoessl, Ryan J Uitti, Ronald F Pfeiffer, Claudia Trenkwalder, Nikolaus Homann, Erwin Ott, Karoline Wenzel, Friedrich Asmus, John Hardy, Zbigniew Wszolek, Thomas Gasser.   

Abstract

Recently, a new locus (PARK8) for autosomal dominant parkinsonism has been identified in one large Japanese family. Linkage has been shown to a 16-cM centromeric region of chromosome 12, between markers D12S1631 and D12S339. We tested 21 white families with Parkinson disease and an inheritance pattern compatible with autosomal dominant transmission for linkage in this region. Criteria for inclusion were at least three affected individuals in more than one generation. A total of 29 markers were used to saturate the candidate region. One hundred sixty-seven family members were tested (84 affected and 83 unaffected). Under the assumption of heterogeneity and through use of an affecteds-only model, a maximum multipoint LOD score of 2.01 was achieved in the total sample, with an estimated proportion of families with linkage of 0.32. This LOD score is significant for linkage in a replication study and corresponds to a P value of.0047. Two families (family A [German Canadian] and family D [from western Nebraska]) reached significant linkage on their own, with a combined maximum multipoint LOD score of 3.33, calculated with an affecteds-only model (family A: LOD score 1.67, P=.0028; family D: LOD score 1.67, P=.0028). When a penetrance-dependent model was calculated, the combined multipoint LOD score achieved was 3.92 (family A: LOD score 1.68, P=.0027; family D: LOD score 2.24, P=.0007). On the basis of the multipoint analysis for the combined families A and D, the 1-LOD support interval suggests that the most likely disease location is between a CA repeat polymorphism on genomic clone AC025253 (44.5 Mb) and marker D12S1701 (47.7 Mb). Our data provide evidence that the PARK8 locus is responsible for the disease in a subset of families of white ancestry with autosomal dominant parkinsonism, suggesting that it could be a more common locus.

Entities:  

Mesh:

Year:  2003        PMID: 14691730      PMCID: PMC1181898          DOI: 10.1086/380647

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  40 in total

1.  Steele-Richardson-Olszewski syndrome in a patient with a single C212Y mutation in the parkin protein.

Authors:  Blas Morales; Armando Martínez; Isabel Gonzalo; Lidice Vidal; Raquel Ros; Estrella Gomez-Tortosa; Alberto Rabano; Israel Ampuero; Marina Sánchez; Janet Hoenicka; Justo García De Yébenes
Journal:  Mov Disord       Date:  2002-11       Impact factor: 10.338

2.  The ubiquitin pathway in Parkinson's disease.

Authors:  E Leroy; R Boyer; G Auburger; B Leube; G Ulm; E Mezey; G Harta; M J Brownstein; S Jonnalagada; T Chernova; A Dehejia; C Lavedan; T Gasser; P J Steinbach; K D Wilkinson; M H Polymeropoulos
Journal:  Nature       Date:  1998-10-01       Impact factor: 49.962

3.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

Authors:  R Krüger; W Kuhn; T Müller; D Woitalla; M Graeber; S Kösel; H Przuntek; J T Epplen; L Schöls; O Riess
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

4.  Complete genomic screen in Parkinson disease: evidence for multiple genes.

Authors:  W K Scott; M A Nance; R L Watts; J P Hubble; W C Koller; K Lyons; R Pahwa; M B Stern; A Colcher; B C Hiner; J Jankovic; W G Ondo; F H Allen; C G Goetz; G W Small; D Masterman; F Mastaglia; N G Laing; J M Stajich; B Slotterbeck; M W Booze; R C Ribble; E Rampersaud; S G West; R A Gibson; L T Middleton; A D Roses; J L Haines; B L Scott; J M Vance; M A Pericak-Vance
Journal:  JAMA       Date:  2001-11-14       Impact factor: 56.272

5.  Lewy bodies and parkinsonism in families with parkin mutations.

Authors:  M Farrer; P Chan; R Chen; L Tan; S Lincoln; D Hernandez; L Forno; K Gwinn-Hardy; L Petrucelli; J Hussey; A Singleton; C Tanner; J Hardy; J W Langston
Journal:  Ann Neurol       Date:  2001-09       Impact factor: 10.422

6.  Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease.

Authors:  D M Maraganore; M J Farrer; J A Hardy; S J Lincoln; S K McDonnell; W A Rocca
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

7.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.

Authors:  H Shimura; N Hattori; S i Kubo; Y Mizuno; S Asakawa; S Minoshima; N Shimizu; K Iwai; T Chiba; K Tanaka; T Suzuki
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

8.  Age at onset in two common neurodegenerative diseases is genetically controlled.

Authors:  Yi-Ju Li; William K Scott; Dale J Hedges; Fengyu Zhang; P Craig Gaskell; Martha A Nance; Ray L Watts; Jean P Hubble; William C Koller; Rajesh Pahwa; Matthew B Stern; Bradley C Hiner; Joseph Jankovic; Fred A Allen; Christopher G Goetz; Frank Mastaglia; Jeffrey M Stajich; Rachel A Gibson; Lefkos T Middleton; Ann M Saunders; Burton L Scott; Gary W Small; Kristin K Nicodemus; Allison D Reed; Donald E Schmechel; Kathleen A Welsh-Bohmer; P Michael Conneally; Allen D Roses; John R Gilbert; Jeffery M Vance; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Am J Hum Genet       Date:  2002-03-01       Impact factor: 11.025

9.  Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism.

Authors:  Vincenzo Bonifati; Patrizia Rizzu; Marijke J van Baren; Onno Schaap; Guido J Breedveld; Elmar Krieger; Marieke C J Dekker; Ferdinando Squitieri; Pablo Ibanez; Marijke Joosse; Jeroen W van Dongen; Nicola Vanacore; John C van Swieten; Alexis Brice; Giuseppe Meco; Cornelia M van Duijn; Ben A Oostra; Peter Heutink
Journal:  Science       Date:  2002-11-21       Impact factor: 47.728

10.  Familial parkinsonism: Our experience and review.

Authors:  M A Denson; Z K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  1995-07       Impact factor: 4.891

View more
  51 in total

1.  Leucine-rich repeat kinase 2: a new player with a familiar theme for Parkinson's disease pathogenesis.

Authors:  Chenjian Li; M Flint Beal
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-07       Impact factor: 11.205

2.  Analysis of the polymorphic prion protein gene codon 129 in idiopathic Parkinson's disease.

Authors:  G Gossrau; B Herting; S Möckel; A Kempe; R Koch; H Reichmann; J B Lampe
Journal:  J Neural Transm (Vienna)       Date:  2005-07-06       Impact factor: 3.575

3.  Parkin modulates gene expression in control and ceramide-treated PC12 cells.

Authors:  P G Unschuld; J Dächsel; F Darios; A Kohlmann; E Casademunt; K Lehmann-Horn; M Dichgans; M Ruberg; A Brice; T Gasser; C B Lücking
Journal:  Mol Biol Rep       Date:  2006-03       Impact factor: 2.316

Review 4.  Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.

Authors:  Malú G Tansey; Melissa K McCoy; Tamy C Frank-Cannon
Journal:  Exp Neurol       Date:  2007-07-17       Impact factor: 5.330

5.  Caenorhabditis elegans neuron degeneration and mitochondrial suppression caused by selected environmental chemicals.

Authors:  Shaoyu Zhou; Zemin Wang; James E Klaunig
Journal:  Int J Biochem Mol Biol       Date:  2013-12-15

6.  LRRK2 G2019S Mutation Inhibits Degradation of α-Synuclein in an In Vitro Model of Parkinson's Disease.

Authors:  Dan Hu; Jian-Yi Niu; Jing Xiong; Shu-Ke Nie; Fei Zeng; Zhao-Hui Zhang
Journal:  Curr Med Sci       Date:  2018-12-07

7.  Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations.

Authors:  Jennifer Kachergus; Ignacio F Mata; Mary Hulihan; Julie P Taylor; Sarah Lincoln; Jan Aasly; J Mark Gibson; Owen A Ross; Timothy Lynch; Joseph Wiley; Haydeh Payami; John Nutt; Demetrius M Maraganore; Krzysztof Czyzewski; Maria Styczynska; Zbigniew K Wszolek; Matthew J Farrer; Mathias Toft
Journal:  Am J Hum Genet       Date:  2005-02-22       Impact factor: 11.025

Review 8.  Analysis of mitochondrial structure and function in the Drosophila larval musculature.

Authors:  Zong-Heng Wang; Cheryl Clark; Erika R Geisbrecht
Journal:  Mitochondrion       Date:  2015-12-01       Impact factor: 4.160

9.  The therapeutic potential of LRRK2 and alpha-synuclein in Parkinson's disease.

Authors:  Saurabh Sen; Andrew B West
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

10.  Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration.

Authors:  Elpida Tsika; Meghna Kannan; Caroline Shi-Yan Foo; Dustin Dikeman; Liliane Glauser; Sandra Gellhaar; Dagmar Galter; Graham W Knott; Ted M Dawson; Valina L Dawson; Darren J Moore
Journal:  Neurobiol Dis       Date:  2014-08-29       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.